NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Vitamin D3 Supplementation in Patients With HIV: Effects on Interleukin-6 Levels and CD4 Counts

CompletedNA

Sponsor: Universitas Sebelas Maret

Conditions: Human Immunodeficiency Virus (HIV)

Interventions: Vitamin D3, Antiretroviral (ARV) medications

Countries: Indonesia

This study aims to evaluate the effect of Vitamin D3 supplementation on inflammatory markers and immune status in patients with HIV who are receiving antiretroviral therapy. Participants will receive Vitamin D3 supplementation for 3 months. Outcomes including Interleukin-6 levels and CD4 counts will be measured to assess the potential benefits of this intervention.

Eligibility overview

Sex: ALL

Age: 19 Years to 59 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Patients diagnosed with HIV stage 1 or 2 who have been receiving antiretroviral therapy (ART) with a TLD regimen for at least 6 months at Dr. Moewardi General Hospital, Surakarta, Indonesia
* Age 19 to 59 years
* Willing to participate in the study and provide informed consent
* Not currently taking any other vitamin supplements

Exclusion Criteria:

* Patients who discontinue treatment (dropout) or die during the study period
* Patients who experience allergic reactions to Vitamin D3 supplementation

Locations (1)

Surakarta, Central Java, Indonesia